CEDAR KNOLLS, N.J.--(BUSINESS WIRE)--Nuvera Life Science Consulting, an expert advisor on patient-centric experience strategies for specialty therapeutics, has completed its second industry benchmark study in oncology: The PURE Report: Oncology 2020.
The pharmaceutical industry spends hundreds of millions of dollars designing and executing patient support programs for rare-disease therapies, yet manufacturers may not clearly understand how these programs are perceived by healthcare providers and where improvements might be made. The PURE Report is an independent industry assessment based on feedback from 500 HCPs to gauge program utilization, satisfaction, and perceptions around evolving needs, allowing Nuvera to quantitatively outline which companies are performing best in supporting patients, caregivers, and HCPs.
Nuvera’s comprehensive analysis consists of two detailed summaries: 1) a syndicated section that measures general trends in HCP perception of various program interactions, their actual service expectations, and their preferred manufacturer programs; and 2) a custom company-specific option, which analyzes manufacturer rankings across Nuvera’s validated PURE indices, spotlighting the company purchasing the report.
“The insights we gain from our benchmarking efforts get more exciting with each iteration of The PURE Report we complete,” said Jens Kulstad, The PURE Report lead. “We evolved our 2020 oncology study to explore multiple different areas, such as pinpointing digital trends in HCP technology use over conventional channels and how company and program utilization compares with that of other therapeutic areas.”
The PURE Report: Oncology 2020 is now available to industry. Exploration areas include:
- Changing use of technology: Gain insight into the channels preferred by prescribing physicians and their staff as it relates to enrolling patients and coordinating support.
- Optimizing enrollment: Understand which companies HCPs consider best at streamlining the enrollment process for patients and offices into various support programs.
- Enhancing HCP-rep engagements: Uncover HCP preferences for field representative qualities and visit frequency when communicating patient support offerings.
- Who’s doing it best: Understand both aided and unaided rankings of company patient support programs, most trusted teams, and specialty pharmacy/distribution network perceptions.
Nuvera will review highlights from the research upon request. If interested, contact Nuvera at contact@thepurereport.com or visit thepurereport.com.
About Nuvera Life Science Consulting
Nuvera Life Science Consulting helps the world’s leading and up-and-coming pharmaceutical and biotech companies deliver impactful patient and HCP support experiences for specialty and rare-disease therapies. Nuvera excels at uncovering patient/HCP needs and crafting and helping to execute seamless treatment experiences that enhance patients’ ability to obtain, start, and stay on therapies. To learn more, please visit nuveracg.com.
"pure" - Google News
July 21, 2020 at 09:17PM
https://ift.tt/2CYTerl
Nuvera Launches The PURE Report: Oncology 2020, Explores Current and Evolving HCP Satisfaction with Pharma Support Programs - Business Wire
"pure" - Google News
https://ift.tt/3d6cIXO
https://ift.tt/35ryK4M
Bagikan Berita Ini
0 Response to "Nuvera Launches The PURE Report: Oncology 2020, Explores Current and Evolving HCP Satisfaction with Pharma Support Programs - Business Wire"
Post a Comment